Dabigatran Etexilate in Atrial Fibrillation Patients with Severe Renal Impairment – Dose Identification using Pharmacokinetic Modeling and Simulation
Authors
Lehr T, Haertter S; Liesenfeld K-H, Staab A, Clemens A, Reilly PA, Friedman J
Journal
J Clin Pharmacol
Publication Date
2012
Impact Factor
2.841
Abstract
Additional IDs
Dabigatran Etexilate in Atrial Fibrillation Patients with Severe Renal Impairment – Dose Identification using Pharmacokinetic Modeling and Simulation - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens